InsiderTrades

Form 4 for PTCT PTC THERAPEUTICS, INC.

Accepted 2023-04-04 00:00:00 ET · period of report 2023-03-31 · accession 0001415889-23-005991 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-04-04 2023-03-31 PTCT SOUTHWELL DAVID P Dir M - OptEx $18.01 +2,571 13.1K +24% +$46.3K
D 2023-04-04 2023-03-31 PTCT SOUTHWELL DAVID P Dir S - Sale+OE $50.05 -2,571 10.5K -20% -$128.7K
D 2023-04-04 2023-03-31 PTCT SOUTHWELL DAVID P Dir M - OptEx $18.01 -2,571 11.4K -18% -$46.3K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-03-31 M A 2,571 $18.01 13,071 D — —
2 Common Common Stock 2023-03-31 S D 2,571 $50.05 10,500 D — — (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $50.00 to $50.17 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
3 Derivative Stock Option (Right to Buy) 2023-03-31 M D 2,571 $18.01 11,429 D $18.01 · — to 2028-01-02 2,571 Common Stock (F3) Currently exercisable.